9 results
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
Anticoagulation INR Targets ... monotherapy (2017 AHA/ACC ... valve (2017 AHA/ACC ... #Management #Cardiology ... #DOAC #Table #Replacement
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... summarizes the A1C ... pharmacotherapy #table ... #comparison #management ... #medications #diabetes
Optimal glycemic control is fundamental to the management of diabetes.

A1C% measurement approximately every 3 months determines
fundamental to the management ... A1C% measurement ... The frequency of A1C ... 2 diabetes, an A1C ... decisionaid #treatment #table
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
Diagnosis and Management ... PostPrandial Insulin A1c ... Targets: • 7.1 ... Rubella) • Medications ... #Management #algorithm
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Table of Common ... Agents via AHA/ACC ... HRS Guidelines #Management ... #Afib #Common #Medications ... #RateControl #Table
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
different than other medications ... to effects or target ... has a smaller A1c ... very tolerable medication ... #Pharmacology #Management
Takotsubo Cardiomyopathy on POCUS Echocardiogram

50's male CAP on Day 4 Zpak but worsening-fever, congestion, cough. BP
Takotsubo Cardiomyopathy ... BP stable. ... consistent with Takotsubo ... #Cardiomyopathy ... ultrasound #Cardiology #a4c
â–º
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
getting patients on medication ... both of these medications ... them up to the target ... recommended by the ACC ... #Pharmacology #Management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... event, follow ACC ... Stable patients ... indication of AC ... medical and surgical management